A prospective , double blind, randomised controlled trial evaluating the effects of mitomycin C on postoperative healing following endoscopic sinus surgery (ESS) to the frontonasal recess.
| ISRCTN | ISRCTN42522811 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN42522811 |
| Protocol serial number | N0256159712 |
| Sponsor | Department of Health |
| Funders | The Royal Free Hampstead NHS Trust (UK), Professorial Unit RNTNE, NHS R&D Support Funding |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 10/07/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Valerie J Lund
Scientific
Scientific
Department of ENT, RNTNE
Royal Free Hampstead NHS Trust
330 Grays Inn Road
King's Cross
London
WC1X 8DA
United Kingdom
| Phone | +44 (0)20 7915 1300 |
|---|---|
| v.lund@ucl.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | The study aims to evaluate the effects of mitomycin C on wound healing, its effects in the prevention of the formation of adhesions as well as preventing restenosis. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Surgery: Endoscopic sinus surgery (ESS) |
| Intervention | Patients undergoing ESS to the frontonasal recess for chronic rhinosinusitis are randomly allocated to receive either MMC or placebo solution applied to the frontonasal recess. |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | mitomycin C |
| Primary outcome measure(s) |
1. Patency of the frontonasal recess. |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/01/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 20 |
| Key inclusion criteria | Not provided at time of registration |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/01/2005 |
| Date of final enrolment | 01/01/2006 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Department of ENT, RNTNE
London
WC1X 8DA
United Kingdom
WC1X 8DA
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results of pilot study | 01/11/2006 | Yes | No |